- Home
- SLSN vs OSUR Comparison
SLSN vs OSUR Comparison
Compare SLSN & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLSN
- OSUR
- Stock Information
- Founded
- SLSN 1989
- OSUR 2000
- Country
- SLSN United States
- OSUR United States
- Employees
- SLSN N/A
- OSUR N/A
- Industry
- SLSN
- OSUR Medical/Dental Instruments
- Sector
- SLSN
- OSUR Health Care
- Exchange
- SLSN NYSE
- OSUR Nasdaq
- Market Cap
- SLSN 218.7M
- OSUR 223.0M
- IPO Year
- SLSN N/A
- OSUR 1986
- Fundamental
- Price
- SLSN $3.36
- OSUR $2.60
- Analyst Decision
- SLSN
- OSUR Hold
- Analyst Count
- SLSN 0
- OSUR 2
- Target Price
- SLSN N/A
- OSUR $5.50
- AVG Volume (30 Days)
- SLSN 114.4K
- OSUR 444.5K
- Earning Date
- SLSN 05-05-2025
- OSUR 05-07-2025
- Dividend Yield
- SLSN N/A
- OSUR N/A
- EPS Growth
- SLSN N/A
- OSUR N/A
- EPS
- SLSN 0.05
- OSUR N/A
- Revenue
- SLSN $57,104,000.00
- OSUR $161,626,000.00
- Revenue This Year
- SLSN N/A
- OSUR N/A
- Revenue Next Year
- SLSN N/A
- OSUR $7.55
- P/E Ratio
- SLSN $60.15
- OSUR N/A
- Revenue Growth
- SLSN 51.44
- OSUR N/A
- 52 Week Low
- SLSN $1.56
- OSUR $2.69
- 52 Week High
- SLSN $3.36
- OSUR $5.59
- Technical
- Relative Strength Index (RSI)
- SLSN N/A
- OSUR 30.12
- Support Level
- SLSN N/A
- OSUR $2.91
- Resistance Level
- SLSN N/A
- OSUR $3.09
- Average True Range (ATR)
- SLSN 0.00
- OSUR 0.11
- MACD
- SLSN 0.00
- OSUR -0.02
- Stochastic Oscillator
- SLSN 0.00
- OSUR 26.47
About SLSN SOLESENCE INC
Solesence Inc is a scientifically driven health care solutions company across beauty and life science categories, protecting skin from environmental aggressors and enhancing the aesthetic appeal of healthy products. The group is engaged in the beauty category that develops and manufactures clean, inclusive, mineral-based skincare and makeup products at the forefront of skin health. Its brands are Stress Defense, Kleair, and Bloom.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.